Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 3-pyrrolidinol, 1-(phenylmethyl)-, (3S)- | 101385-90-4 | MFCD00075485 | 99.9% | 177.25 g·mol⁻¹ | C11H15NO | 10 G
SDP

Catalog No. 5000301837
Encompass_Preferred

(S)-1-Benzylpyrrolidin-3-ol (CAS 101385-90-4) is a chiral pyrrolidinol intermediate used in small-molecule synthesis and impurity characterization. Manufacturer documentation provides solubility, storage, and handling guidance for research applications and formulation testing.

  • Chiral pyrrolidinol intermediate for synthetic chemistry.
  • Molecular formula C11H15NO.
  • Molecular weight 177.25 g·mol⁻¹.
  • High purity (reported ~99.9%).
  • Soluble in DMSO (200 mg/mL in vitro) and compatible with common in vivo vehicles.
  • Suggested storage: pure form -20°C (long term) or 4°C (shorter term).

Catalog No. 50-003-01837 Supplier Medchemexpress LLC Supplier No. HYW01664410G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(S)-1-Benzylpyrrolidin-3-ol (CAS 101385-90-4) is a chiral pyrrolidinol intermediate used in small-molecule synthesis and impurity characterization. Manufacturer documentation provides solubility, storage, and handling guidance for research applications and formulation testing.

  • Chiral pyrrolidinol intermediate for synthetic chemistry.
  • Molecular formula C11H15NO.
  • Molecular weight 177.25 g·mol⁻¹.
  • High purity (reported ~99.9%).
  • Soluble in DMSO (200 mg/mL in vitro) and compatible with common in vivo vehicles.
  • Suggested storage: pure form -20°C (long term) or 4°C (shorter term).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.